Company Data

Outlook Therapeutics Inc.

Ticker
OTLK
Current Price
$1.71 -8.56%
Market Cap
$42.6M
Price Target
Refer to Report
Volume
697.3K
52wk Range
$0.87 - $12.8499
Advanced Market Data

Overview

Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy